
Sign up to save your podcasts
Or


The Latest Malaria News, in 60 Seconds.
New mutations to the quinoline drug family identified in South America and Asia are not prevalent in Africa and scientists evaluate a new field-based malaria blood test.
More: www.fightmalaria.uk/MalariaMinute
The Latest Malaria News, in 60 Seconds.
Artefenomel is assessed against Plasmodium vivax infection in humans to determine the minimum effective dose required for parasite clearance and LSHTM launch a beta version of The Global Vector Hub.
More: www.fightmalaria.uk/MalariaMinute
The Latest Malaria News, in 60 Seconds.
The spleen plays a major role in the expression of P. vivax genes and in the production of antigens associated with clinical protection, and scientists develop an AI that can detect Plasmodium infection in the blood.
More: www.fightmalaria.uk/MalariaMinute
The Latest Malaria News, in 60 Seconds.
The BioMalPar conference takes place online and the synchronisation of Plasmodium infection is controlled by the parasite’s own internal clock.
More: www.fightmalaria.uk/MalariaMinute
The Latest Malaria News, in 60 Seconds.
Antibody tests for P. vivax malaria could reduce disease prevalence by up to 69% and scientists develop a sex-distorter gene drive that eliminates populations of mosquitoes in the lab.
More: www.fightmalaria.uk/MalariaMinute
The Latest Malaria News, in 60 Seconds.
Scientists find that microsporidia MB stops malaria transmission in Anopheles arabiensis mosquitoes by disrupting oocyst formation.
More: www.fightmalaria.uk/MalariaMinute
The Latest Malaria News, in 60 Seconds.
The combined use of mass drug administration and indoor residual spraying is the most effective way to reduce malaria prevalence in low malaria-endemic settings, and antibodies against PfGARP kill malaria-infected cells by inducing cell death.
More: www.fightmalaria.uk/MalariaMinute
The Latest Malaria News, in 60 Seconds.
A summary of where we are in the fight against malaria and an overview of what more needs to be done.
More: www.fightmalaria.uk/MalariaMinute
The Latest Malaria News, in 60 Seconds.
Genetic variation would seem to have little impact on the outcome of gene drive interventions due to conserved Cas9 target sites in populations of Anopheles mosquitoes.
More: www.fightmalaria.uk/MalariaMinute
The Latest Malaria News, in 60 Seconds.
Results from the first human trial of the novel antimalarial drug SJ733 are published in The Lancet.
More: www.fightmalaria.uk/MalariaMinute
From the publisher's feed